Abstract:BackgroundPrimary central nervous system lymphoma (PCNSL) is a rare, aggressive brain neoplasm that accounts for roughly 2-6% of primary brain tumors. In contrast, glioblastoma (GBM) is the most frequent and severe glioma subtype, accounting for approximately 50% of diffuse gliomas. The aim of the present study was to evaluate morphological MRI characteristics in histologically-proven PCNSL and GBM at the time of their initial presentation.MethodsWe retrospectively evaluated standard diagnostic MRI examinations in 54 immunocompetent patients (26 female, 28 male; age 62.6 ± 11.5 years) with histologically-proven PCNSL and 54 GBM subjects (21 female, 33 male; age 59 ± 14 years).ResultsSeveral significant differences between both infiltrative brain tumors were found. PCNSL lesions enhanced homogenously in 64.8% of cases, while nonhomogeneous enhancement was observed in 98.1% of GBM cases. Necrosis was present in 88.9% of GBM lesions and only 5.6% of PCNSL lesions. PCNSL presented as multiple lesions in 51.9% cases and in 35.2% of GBM cases; however, diffuse infiltrative type of brain involvement was observed only in PCNSL (24.1%). Optic pathways were infiltrated more commonly in PCNSL than in GBM (42.6% vs. 5.6%, respectively, p <0.001). Other cranial nerves were affected in 5.6% of PCNSL, and in none of GBM. Signs of bleeding were rare in PCNSL (5.6%) and common in GBM (44.4%); p < 0.001. Both supratentorial and infratentorial localization was present only in PCNSL (27.7%). Involvement of the basal ganglia was more common in PCNSL (55.6%) than in GBM (18.5%); (p < 0.001). Cerebral cortex was affected significantly more often in GBM (83.3%) than in PCNSL (51.9%); mostly by both enhancing and non-enhancing infiltration.ConclusionRoutine morphological MRI is capable of differentiating between GBM and PCNSL lesions in many cases at time of initial presentation. A solitary infiltrative supratentorial lesion with nonhomogeneous enhancement and necrosis was typical for GBM. PCNSL presented with multiple lesions that enhanced homogenously or as diffuse infiltrative type of brain involvement, often with basal ganglia and optic pathways affection.

MR imaging features of intracranial primary CNS lymphoma in immune competent patients

Primary lymphomas in the brain: MR findings

MRI Findings of Primary CNS Lymphoma in 26 Immunocompetent Patients

Imaging Features of Immunodeficiency-Associated Primary CNS Lymphoma: A Review

MRI and 1 H-MRS Characteristics of Primary Central Nervous System Lymphomas (PCNSL)

Primary central nervous system lymphoma: advances in MRI and PET imaging

Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma

Primary central nervous system lymphomas in immunocompromised patients require specific response criteria

MRI Diagnosis of Primary Central Nervous System Diffuse Large B-cell Lymphoma

Atypical MRI Manifestations of Primary Central Nervous System Lymphoma

Multiparametric differentiation of intracranial central nervous system lymphoma and high-grade glioma using diffusion-, perfusion-, susceptibility-weighted magnetic resonance imaging, and spectroscopy

Anaysis of MRI Manifestations of 37 Cases of Primary Central Nervous System Lymphoma

The Utility of Multiparametric Magnetic Resonance Imaging in Reducing Diagnostic Uncertainty for Primary Central Nervous System Lymphoma

Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?

Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative review

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

Primary Central Nervous System Lymphoma: From Clinical Presentation to Diagnosis

Primary central nervous system lymphoma: presentation, diagnosis, and staging

Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging

MRI-Based Machine Learning for Prediction of Clinical Outcomes in Primary Central Nervous System Lymphoma

Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man